to Content
Header Image

Fair Society, Healthy Lives

-
Erwin-Schrödinger-Saal
Plenary / Keynote & Discussion
english language

How can social determinants of health, the conditions in which people are born, grow up, live, work and age, lead to health inequalities? How can we reduce these inequalities? What factors contribute to achieve an equitable and healthy society and what are the greatest obstacles?

Speakers

Director, Institute of Health Equity, UCL Research Department of Epidemiology and Public Health, London Abstract Key Note
Indicators of overall population health and the distribution of health tell us much about how well a society is doing. The WHO Commission on Social Determinants of Health advocated for action on the wider social, economic, political and cultural determinants of health in order to improve population health and reduce health inequalities. Sir Michael will discuss learning from the Commission on Social Determinants of Health, the Strategic Review of Health Inequalities in England (Marmot Review), and the WHO Review of Social Determinants of Health and the Health Divide and how it can be applied in different contexts nationally and locally to build fairer and healthier societies.
Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna Chair

Ph.D. Michael MARMOT

Director, Institute of Health Equity, UCL Research Department of Epidemiology and Public Health, London

1966 B.Sc.(Hons), University of Sydney
1968 MBBS Study of Medicine, University of Sydney
1972 MPH - Master of Public Health, Epidemiology, University of California, Berkeley
1975 Ph.D., Epidemiology, University of California, Berkeley
1976 Adjunct Associate Professor, School of Health, University of Texas
1976-1985 Lecturer and Hon. Senior Lecturer, London School of Hygiene and Tropical Medicine, London
1985 Professor of Epidemiology and Public Health, University College London
1985-2011 Head of Department, Epidemiology & Public Health, University College London
1990-1992 Professor, Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London
1994-2005 Director of the International Institute for Society and Health, University College London
1995 Member of the Royal Commission Research Professor in Epidiemology
since 2000 Adjunct Professor, Department of Society, Human Development and Health, Harvard University, Cambridge, Massachusetts
2005 Director, International Institute for Society and Health, University College London
2007-2008 Associate, Health Policy & Management, Johns Hopkins, Baltimore, Maryland
since 2011 Director, Institute of Health Equity, University College London

Dr. Prof. Giulio SUPERTI-FURGA

Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna

 Studium Molekulare Biologie (Universität Zürich, Genentech Inc. - San Francisco, Research Institut für Molekulare Pathologie - Wien)
 Wissenschaftlicher Mitarbeiter, Europäisches Laboratorium für Molekularbiologie (EMBL), Heidelberg
1995 Teamleiter, Europäisches Laboratorium für Molekularbiologie (EMBL), Heidelberg
1997-2000 Gastprofessur, Molekulare Biologie, Universität Bologna
2000 Mitgründer und Wissenschaftlicher Direktor, Biotech-Firma Cellzome Inc.
 Zu seinen bedeutendsten wissenschaftlichen Errungenschaften zählen die Aufklärung grundlegender Regulationsmechanismen von Tyrosin-Kinasen, die bei menschlichen Krebserkrankungen von Bedeutung sind, sowie die Entdeckung entscheidender Organisationsgrundsätze des Proteoms höherer Organismen. Seine Arbeit hat direkt zu einem systematischen Verständnis von Infektionen durch Krankheitserreger sowie der Wirkmechanismen bestimmter Arzneistoffe beigetragen. Er ist ein Fürsprecher systembiologischer Ansätze in der Medizin und der Arzneimittelforschung und hat sich zum Ziel gesetzt, Grundlagen- und klinische Forschung zu verknüpfen
seit 2005 Wissenschaftlicher Direktor, CeMM; Gastprofessor für Molekulare Pharmakologie, Medizinischen Universität Wien

Health Symposium

show timetable

16.08.2013

13:00 - 13:15OpeningPlenary
13:15 - 14:30Fair Society, Healthy LivesPlenary
15:00 - 16:30How Reliable is Evidence in Medicine?Plenary
17:00 - 18:00Indroduction to the Main Topics of the Working GroupsPlenary

16.08.-19.08.2013

AUVA: Austrian Charta of PreventionPartner

17.08.2013

05:00 - 08:00Sunrise Hike with Peter HabelerSocial
09:30 - 13:00Working Group 01: Creating Knowledge: Which Freedoms Should Clinical Research Have?Breakout
09:30 - 13:00Working Group 02: Sharing Knowledge: Communication in MedicineBreakout
09:30 - 13:00Working Group 03: Applying Knowledge: Who Is to Take Decisions? Who Is to Set Priorities?Breakout
09:30 - 13:00Working Group 04: Implementing Knowledge: What is the Value of Health?Breakout
13:30 - 15:00BILLA: Who Makes the Decision on Health at the Supermarket?Partner
16:00 - 18:30Reception on the HillSocial
20:00 - 21:30Lüder Wohlenberg "Spontaneous Recovery"Plenary
21:30 - 23:00Student Lounge hosted by PHARMIG - Association of the Austrian Pharmaceutical IndustrySocial

18.08.2013

16:30 - 18:00Presentation of the Working Group ResultsPlenary
20:30 - 23:30Reception hosted by PHARMIG - Association of the Austrian Pharmaceutical IndustryPartner

19.08.2013

09:00 - 10:30Putting Evidence into Policy Practice - Learning from the BestPlenary
11:00 - 12:30Responsibility for Setting the Agenda for Health Care PolicyPlenary
12:30 - 12:45Closing RemarksPlenary
16:30 - 20:30FOPI: The Future of the Healthcare Reform 2013 - 2018. Requirements for a Successful ImplementationPartner